Atara Biotherapeutics Inc. buy melinda
Start price
12.03.20
/
50%
€7.27
Target price
17.03.20
€12.00
Performance (%)
-20.36%
End price
17.03.20
€5.79
Summary
This prediction ended on 17.03.20 with a price of €5.79. The prediction for Atara Biotherapeutics Inc. disappointed with a performance of -20.36%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Atara Biotherapeutics Inc. | 8.604% | 8.604% | -66.906% | -94.326% |
| iShares Core DAX® | -1.347% | 3.576% | 14.229% | 18.356% |
| iShares Nasdaq 100 | 1.169% | 7.020% | 35.388% | 58.850% |
| iShares Nikkei 225® | -0.327% | -0.673% | 8.618% | 6.718% |
| iShares S&P 500 | 0.510% | 4.445% | 28.019% | 49.406% |
According to melinda what are the pros and cons of Atara Biotherapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Atara Biotherapeutics Inc. diskutieren
Buy mit Kursziel 12,0
In the thread Trading Atara Biotherapeutics Inc.
Stopped prediction by melinda for Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€5.79
17.03.20
17.03.20
€15.00
04.11.21
04.11.21
200.79%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Atara Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€36.68
03.04.19
03.04.19
€40.59
30.10.19
30.10.19
-73.34%
30.10.19
30.10.19
Could be worthwhile Investment >10% per year
Atara Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€25.35
13.01.18
13.01.18
€28.41
22.01.18
22.01.18
15.84%
22.01.18
22.01.18
Could be worthwhile Investment >10% per year